Bakersfield Buprenorphine Doctors


Feature Your Practice at the Top of This City Page

Locate Bakersfield buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.

Dr. George Ibrahim Girgis, M.D.
1018 21st Street
Bakersfield, CA 93301
Main Tel: (661) 861-9967
Jan H. Trobisch, M.D.
4100 Empire Drive
Suite #120
Bakersfield, CA 93309
Main Tel: (661) 878-9100
Dr. Edwin Y. Zong, D.O.
212 Goodman Street
Bakersfield, CA 93305
Main Tel: (661) 633-9753
Dr. Sarupinder S. Bhangoo, M.D.
1010 1/2
South Union Avenue
Bakersfield, CA 93307
Main Tel: (661) 321-0234
Dr. Shailesh C. Patel,
1600 East Bell Terrace
Bakersfield, CA 93307
Main Tel: (661) 635-2950
Franco Song Seo, M.D.
6001 Truxtun Avenue
Suite 160
Bakersfield, CA 93309
Main Tel: (661) 323-6410
Dr. Iyengar Malini, M.D.
6001Truxtun Avenue
Suite 160
Bakersfield, CA 93309
Main Tel: (661) 323-6410
Ravi Kumar Goklaney, M.D.
Advanced Medical Psychiatric Services
3409 Calloway Drive # 601
Bakersfield, CA 93312
Main Tel: (661) 589-1200
Dr. Rizwana Shaheen, M.D.
5106 Boulder Creek Place
Bakersfield, CA 93312
Main Tel: (661) 679-7138
Dr. Peter Julian Liepmann, M.D.
11506 Vauxhall Bridge Drive
Bakersfield, CA 93311
Main Tel: (518) 302-6006
Surinder K. Sidhu, M.D.
9739 Gosford Road
Bakersfield, CA 93313
Main Tel: (661) 396-7668
Bruce Taylor, D.O.
8787 Hall Road
Lamont, CA 93241
Main Tel: (661) 328-4295

Sublocade Now Available

Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More

Posted in Buprenorphine, Medication-Assisted Treatment | Tagged | Leave a comment

Ohio Increases Buprenorphine Access

In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More

Posted in Addiction Medications, Buprenorphine, Medication-Assisted Treatment, Suboxone | Tagged , | Leave a comment

The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.

Buprenorphine is the medication ingredient in Suboxone, Subutex, Zubsolv, Bunavail, and Probuphine that specifically targets opioid withdrawal. Buprenorphine, or "Bup", is the leading pharmaceutical treatment (alongside methadone) for addressing opioid addiction. Both medications are in widescale use throughout the world due to their efficacy in removing the persistent discomfort associated with withdrawal from opiates (ex. runny nose, body ache, anxiety, nausea, diarrhea and other symptoms).

Buprenorphine.US is an information resource for people in search of doctors who specialize in treating opioid addiction with buprenorphine. In recent years, individuals from all age groups and backgrounds have suffered with an unexpected opioid dependency that negatively affected their family relationships, job, finances, and self-esteem. Addiction is a relentless illness, and persistent opiate withdrawal is a particularly difficult medical dilemma. There are presently thousands of U.S. physicians seeking to assist patients ready to address their opioid addiction. Buprenorphine.US is a tool for connecting buprenorphine doctors with new prospective patients wanting specialized primary care for their addictive disorder.